Lundbeck UK appoints senior management team
pharmafile | November 2, 2010 | News story | Research and Development, Sales and Marketing | Amanda Badrick, Andy Davis, Andy Jones, Helen Carberry, Lundbeck, Steve Ferguson, appointment, recruitment, research and development, sales and marketing
Lundbeck UK has formed a new senior management team, appointing Steve Ferguson, Andy Davis, Andy Jones, Helen Carberry and Amanda Badrick.
Steve Ferguson takes on a new role of commercial director and has been tasked with ensuring an integrated and highly skilled marketing and market access approach.
Andy Davis joins Lundbeck as sales director and brings a wealth of experience from his past leadership positions in United Drug and Takeda.
Andy Jones has also recently joined Lundbeck as medical director, and brings experience from past UK and international roles.
Helen Carberry and Amanda Badrick have both taken on new roles within Lundbeck to head the HR and Finance functions respectively.
The five will join managing director Steve Turley on Lundbeck’s senior management team and will work with the rest of the organisation to help further establish it in the UK.
Related Content
Otsuka and Lundbeck gain FDA approval for supplemental New Drug Application for dementia drug
Japan-based healthcare company Otsuka Pharmaceutical and Danish pharma company Lundbeck have announced that the US …
Lundbeck to restructure R&D, shedding up to 160 jobs
Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research …
Lundbeck’s Vyepti secures US approval for migraine prevention
Lundbeck’s Vyepti (eptinezumab-jjmr) has secured approval from the FDA, it has emerged, for the prevention …